Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. (Q36357779)

13 August 2017

Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. (English)

1 reference

13 August 2017

John G F Cleland

1

1 reference

13 August 2017

Nick Freemantle

series ordinal

2

1 reference

13 August 2017

Alison P Coletta

series ordinal

3

1 reference

13 August 2017

Andrew L Clark

series ordinal

4

1 reference

13 August 2017

language of work or name

1 reference

1 January 2006

1 reference

European Journal of Heart Failure

13 August 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

13 August 2017

8

1 reference

13 August 2017

105-110

1 reference

13 August 2017

1

1 reference

Haematopoietic stem cells improve cardiac function after infarction without permanent cardiac engraftment

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

Clinical trials update from the American Heart Association meeting: Omega-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, OR

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

Levosimendan: a new era for inodilator therapy for heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.003

10.1016/J.EJHEART.2005.12.003

21 January 2018

Identifiers

DOI

1 reference

release_ecizfzqc45bnnmyhtsbvhknxjq

13 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ecizfzqc45bnnmyhtsbvhknxjq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference